180 related articles for article (PubMed ID: 24313979)
1. Expression and prognostic significance of golgiglycoprotein73 (GP73) with epithelial-mesenchymal transition (EMT) related molecules in hepatocellular carcinoma (HCC).
Bao YX; Cao Q; Yang Y; Mao R; Xiao L; Zhang H; Zhao HR; Wen H
Diagn Pathol; 2013 Dec; 8():197. PubMed ID: 24313979
[TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
3. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H
Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054
[TBL] [Abstract][Full Text] [Related]
4. Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC.
Zhai X; Zhu H; Wang W; Zhang S; Zhang Y; Mao G
Med Oncol; 2014 Jun; 31(6):970. PubMed ID: 24781336
[TBL] [Abstract][Full Text] [Related]
5. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
6. Silencing of GP73 inhibits invasion and metastasis via suppression of epithelial-mesenchymal transition in hepatocellular carcinoma.
Yang Y; Liu Q; Zhang H; Zhao H; Mao R; Li Z; Ya S; Jia C; Bao Y
Oncol Rep; 2017 Feb; 37(2):1182-1188. PubMed ID: 28075476
[TBL] [Abstract][Full Text] [Related]
7. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
[TBL] [Abstract][Full Text] [Related]
8. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
10. [Gli1 expression and its relationship with the expression of Shh, Vimentin and E-cadherin in human hepatocellular carcinoma].
Xu QR; Zheng X; Zan XF; Yao YM; Yang W; Liu QG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 May; 28(5):536-9. PubMed ID: 22558994
[TBL] [Abstract][Full Text] [Related]
11. BPTF Associated with EMT Indicates Negative Prognosis in Patients with Hepatocellular Carcinoma.
Xiao S; Liu L; Fang M; Zhou X; Peng X; Long J; Lu X
Dig Dis Sci; 2015 Apr; 60(4):910-8. PubMed ID: 25362514
[TBL] [Abstract][Full Text] [Related]
12. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
Hou KZ; Fu ZQ; Gong H
World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
[TBL] [Abstract][Full Text] [Related]
13. Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell.
Hou X; Yang L; Jiang X; Liu Z; Li X; Xie S; Li G; Liu J
Int J Biol Macromol; 2019 May; 128():331-339. PubMed ID: 30695725
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of CD13 and epithelial mesenchymal transition (EMT) markers in hepatocellular carcinoma.
Yamanaka C; Wada H; Eguchi H; Hatano H; Gotoh K; Noda T; Yamada D; Asaoka T; Kawamoto K; Nagano H; Doki Y; Mori M
Jpn J Clin Oncol; 2018 Jan; 48(1):52-60. PubMed ID: 29145632
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Xu M; Zhen L; Lin L; Wu K; Wang Y; Cai X
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):340-348. PubMed ID: 31422034
[TBL] [Abstract][Full Text] [Related]
16. Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma.
Zhang DY; Lei JS; Sun WL; Wang DD; Lu Z
Chin Med J (Engl); 2020 Aug; 133(15):1798-1804. PubMed ID: 32740091
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of Golgi protein 73 is indicative of a poor outcome in hepatocellular carcinoma.
Jiang K; Li W; Shang S; Sun L; Guo K; Zhang S; Liu Y
Oncol Rep; 2016 Apr; 35(4):2141-50. PubMed ID: 26820712
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas.
Zhai B; Yan HX; Liu SQ; Chen L; Wu MC; Wang HY
World J Gastroenterol; 2008 Oct; 14(37):5665-73. PubMed ID: 18837082
[TBL] [Abstract][Full Text] [Related]
19. Elevated LncRNA TRERNA1 correlated with activation of HIF-1α predicts poor prognosis in hepatocellular carcinoma.
Qian Y; Li Y; Ge Y; Song W; Fan H
Pathol Res Pract; 2021 Nov; 227():153612. PubMed ID: 34560417
[TBL] [Abstract][Full Text] [Related]
20. [Associations between interleukin-17A expression and epithelial-mesenchymal transition in patients with hepatocellular carcinoma].
Xu J; Wang J; Hu Y; Cheng L; Yu H
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):585-90. PubMed ID: 26714598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]